Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6


Murine cytomegalovirus infection of melanoma lesions delays tumor growth by recruiting and re-polarizing monocytic phagocytes in the tumor.

Wilski NA, Del Casale C, Purwin TJ, Aplin AE, Snyder CM.

J Virol. 2019 Aug 2. pii: JVI.00533-19. doi: 10.1128/JVI.00533-19. [Epub ahead of print]


From Vaccine Vector to Oncomodulation: Understanding the Complex Interplay between CMV and Cancer.

Wilski NA, Snyder CM.

Vaccines (Basel). 2019 Jul 9;7(3). pii: E62. doi: 10.3390/vaccines7030062. Review.


Monocarboxylate Transporter 4 (MCT4) Knockout Mice Have Attenuated 4NQO Induced Carcinogenesis; A Role for MCT4 in Driving Oral Squamous Cell Cancer.

Bisetto S, Whitaker-Menezes D, Wilski NA, Tuluc M, Curry J, Zhan T, Snyder CM, Martinez-Outschoorn UE, Philp NJ.

Front Oncol. 2018 Aug 28;8:324. doi: 10.3389/fonc.2018.00324. eCollection 2018.


Intratumoral infection by CMV may change the tumor environment by directly interacting with tumor-associated macrophages to promote cancer immunity.

Erkes DA, Wilski NA, Snyder CM.

Hum Vaccin Immunother. 2017 Aug 3;13(8):1778-1785. doi: 10.1080/21645515.2017.1331795. Epub 2017 Jun 12. Review.


Virus-Specific CD8+ T Cells Infiltrate Melanoma Lesions and Retain Function Independently of PD-1 Expression.

Erkes DA, Smith CJ, Wilski NA, Caldeira-Dantas S, Mohgbeli T, Snyder CM.

J Immunol. 2017 Apr 1;198(7):2979-2988. doi: 10.4049/jimmunol.1601064. Epub 2017 Feb 15.


Intratumoral Infection with Murine Cytomegalovirus Synergizes with PD-L1 Blockade to Clear Melanoma Lesions and Induce Long-term Immunity.

Erkes DA, Xu G, Daskalakis C, Zurbach KA, Wilski NA, Moghbeli T, Hill AB, Snyder CM.

Mol Ther. 2016 Aug;24(8):1444-55. doi: 10.1038/mt.2016.121. Epub 2016 Jun 10.

Supplemental Content

Loading ...
Support Center